 pilot studi suramin treatment metastat renal cell carcinoma suramin sodium aromat compound antiparasit agent view abil function multipl growth factor cellular enzym system author role suramin antitumor agent studi patient metastat renal cell carcinoma parenter suramin continu infus peak plasma suramin level micrograms/ml object radiograph respons necrosi multipl tumor site autopsi patient normal tumor-rel hypercalcemia patient patient stabl diseas week durat signific toxic hypotens sepsi renal insuffici patient develop liver function abnorm patient thrombocytopenia patient prothrombin time prolong patient patient grade sensori neuropathi patient basi current result suramin activ singl agent metastat renal cell carcinoma dose schedul